BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 11390436)

  • 1. Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.
    Levings MK; Sangregorio R; Roncarolo MG
    J Exp Med; 2001 Jun; 193(11):1295-302. PubMed ID: 11390436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells.
    Levings MK; Sangregorio R; Sartirana C; Moschin AL; Battaglia M; Orban PC; Roncarolo MG
    J Exp Med; 2002 Nov; 196(10):1335-46. PubMed ID: 12438424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood.
    Dieckmann D; Plottner H; Berchtold S; Berger T; Schuler G
    J Exp Med; 2001 Jun; 193(11):1303-10. PubMed ID: 11390437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes.
    Annunziato F; Cosmi L; Liotta F; Lazzeri E; Manetti R; Vanini V; Romagnani P; Maggi E; Romagnani S
    J Exp Med; 2002 Aug; 196(3):379-87. PubMed ID: 12163566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human CD4+CD25+ T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production.
    Bellinghausen I; Klostermann B; Knop J; Saloga J
    J Allergy Clin Immunol; 2003 Apr; 111(4):862-8. PubMed ID: 12704370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade.
    Taylor PA; Noelle RJ; Blazar BR
    J Exp Med; 2001 Jun; 193(11):1311-8. PubMed ID: 11390438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment.
    Chiffoleau E; Bériou G; Dutartre P; Usal C; Soulillou JP; Cuturi MC
    J Immunol; 2002 May; 168(10):5058-69. PubMed ID: 11994458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood.
    Jonuleit H; Schmitt E; Stassen M; Tuettenberg A; Knop J; Enk AH
    J Exp Med; 2001 Jun; 193(11):1285-94. PubMed ID: 11390435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses.
    Kingsley CI; Karim M; Bushell AR; Wood KJ
    J Immunol; 2002 Feb; 168(3):1080-6. PubMed ID: 11801641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+CD25high regulatory cells in human peripheral blood.
    Baecher-Allan C; Brown JA; Freeman GJ; Hafler DA
    J Immunol; 2001 Aug; 167(3):1245-53. PubMed ID: 11466340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.
    Takahashi T; Tagami T; Yamazaki S; Uede T; Shimizu J; Sakaguchi N; Mak TW; Sakaguchi S
    J Exp Med; 2000 Jul; 192(2):303-10. PubMed ID: 10899917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquisition of anergic and suppressive activities in transforming growth factor-beta-costimulated CD4+CD25- T cells.
    Park HB; Paik DJ; Jang E; Hong S; Youn J
    Int Immunol; 2004 Aug; 16(8):1203-13. PubMed ID: 15237111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood.
    Yamagiwa S; Gray JD; Hashimoto S; Horwitz DA
    J Immunol; 2001 Jun; 166(12):7282-9. PubMed ID: 11390478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation.
    Read S; Malmström V; Powrie F
    J Exp Med; 2000 Jul; 192(2):295-302. PubMed ID: 10899916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superantigen-induced regulatory T cells display different suppressive functions in the presence or absence of natural CD4+CD25+ regulatory T cells in vivo.
    Grundström S; Cederbom L; Sundstedt A; Scheipers P; Ivars F
    J Immunol; 2003 May; 170(10):5008-17. PubMed ID: 12734345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration.
    Zhang X; Izikson L; Liu L; Weiner HL
    J Immunol; 2001 Oct; 167(8):4245-53. PubMed ID: 11591746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance.
    Graca L; Thompson S; Lin CY; Adams E; Cobbold SP; Waldmann H
    J Immunol; 2002 Jun; 168(11):5558-65. PubMed ID: 12023351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
    Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
    J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted CTLA-4 engagement induces CD4+CD25+CTLA-4high T regulatory cells with target (allo)antigen specificity.
    Vasu C; Prabhakar BS; Holterman MJ
    J Immunol; 2004 Aug; 173(4):2866-76. PubMed ID: 15295006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.